| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 1997;96:1930-1936.)
© 1997 American Heart Association, Inc.
Articles |
Enhanced Endothelin-Mediated Coronary Vasoconstriction and Attenuated Basal Nitric Oxide Activity in Experimental Hypercholesterolemia
From the Division of Cardiovascular Diseases and Internal Medicine, Mayo Foundation, Rochester, Minn.
Correspondence to Amir Lerman, MD, Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905.
Background Experimental hypercholesterolemia is associated with coronary vasomotor dysfunction. This study was designed to test the hypothesis that experimental hypercholesterolemia is characterized by altered coronary vasomotor responses to endothelin and inhibition of the endogenous NO pathway.
Methods and Results Endothelin-1 (ET-1) at 5 ng · kg-1 · min-1 or NG-monomethyl-L-arginine (L-NMMA), a competitive inhibitor of nitric oxide synthase (NOS), at 50 µg · kg-1 · min-1 was infused into the left anterior descending coronary artery in pigs before and after 10 weeks of cholesterol diet. There was a significant increase in serum cholesterol. At 10 weeks, ET-1 resulted in an accentuated decrease in coronary blood flow (CBF) and coronary artery diameter (CAD) compared with baseline (-88±6% versus -45±9%, P<.05, and -77±14% versus -18±8%, P<.05, respectively) and an increase in coronary vascular resistance (CVR) (242±18% versus 110±17%, P<.05); ET receptor density and binding affinity in epicardial coronary arteries were unchanged. The effect of L-NMMA on CBF, CAD, and CVR was attenuated at 10 weeks (-7±8% versus -48±4%, -2±3% versus -17±5%, and 16±10% versus 125±32%; each P<.05). Immunohistochemistry staining for constitutive NOS revealed a decrease in immunoreactivity in the coronary arteries of hypercholesterolemic pigs.
Conclusions The present study demonstrates an enhanced coronary vasoconstrictive response to pathophysiological doses of endothelin and an attenuated response to the inhibition of endogenous NO activity, suggesting an alteration in coronary vascular reactivity in experimental hypercholesterolemia.
Key Words: endothelin • endothelium-derived factors • circulation • hypercholesterolemia
This article has been cited by other articles:
 |
|
 |
|
  S. Lavi, E. H. Yang, A. Prasad, V. Mathew, G. W. Barsness, C. S. Rihal, L. O. Lerman, and A. Lerman The Interaction Between Coronary Endothelial Dysfunction, Local Oxidative Stress, and Endogenous Nitric Oxide in Humans Hypertension, January 1, 2008; 51(1): 127 - 133. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. J. Sampson, L. M. Davies, R. Barrett-Jolley, N. B. Standen, and C. Dart Angiotensin II-activated protein kinase C targets caveolae to inhibit aortic ATP-sensitive potassium channels Cardiovasc Res, October 1, 2007; 76(1): 61 - 70. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. L. Heaps, D. L. Tharp, and D. K. Bowles Hypercholesterolemia abolishes voltage-dependent K+ channel contribution to adenosine-mediated relaxation in porcine coronary arterioles Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H568 - H576. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A.C. Sposito Emerging insights into hypertension and dyslipidaemia synergies Eur. Heart J. Suppl., December 1, 2004; 6(suppl_G): G8 - G12. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Bergdahl, M. F. Gomez, K. Dreja, S.-Z. Xu, M. Adner, D. J. Beech, J. Broman, P. Hellstrand, and K. Sward Cholesterol Depletion Impairs Vascular Reactivity to Endothelin-1 by Reducing Store-Operated Ca2+ Entry Dependent on TRPC1 Circ. Res., October 31, 2003; 93(9): 839 - 847. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ruel, G. F. Wu, T. A. Khan, P. Voisine, C. Bianchi, J. Li, J. Li, R. J. Laham, and F. W. Sellke Inhibition of the Cardiac Angiogenic Response to Surgical FGF-2 Therapy in a Swine Endothelial Dysfunction Model Circulation, September 9, 2003; 108(90101): II-335 - 340. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Rodriguez-Porcel, L. O. Lerman, J. Herrmann, T. Sawamura, C. Napoli, and A. Lerman Hypercholesterolemia and Hypertension Have Synergistic Deleterious Effects on Coronary Endothelial Function Arterioscler. Thromb. Vasc. Biol., May 1, 2003; 23(5): 885 - 891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rodriguez-Porcel, L. O Lerman, D. R Holmes Jr., D. Richardson, C. Napoli, and A. Lerman Chronic antioxidant supplementation attenuates nuclear factor-{kappa}B activation and preserves endothelial function in hypercholesterolemic pigs Cardiovasc Res, March 1, 2002; 53(4): 1010 - 1018. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Sterzer, F. Meintzschel, A. Rosler, H. Lanfermann, H. Steinmetz, and M. Sitzer Pravastatin Improves Cerebral Vasomotor Reactivity in Patients With Subcortical Small-Vessel Disease Stroke, December 1, 2001; 32(12): 2817 - 2820. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. STULAK, A. LERMAN, M. R. PORCEL, J. A. CACCITOLO, J. C. ROMERO, H. V. SCHAFF, C. NAPOLI, and L. O. LERMAN Renal Vascular Function in Hypercholesterolemia Is Preserved by Chronic Antioxidant Supplementation J. Am. Soc. Nephrol., September 1, 2001; 12(9): 1882 - 1891. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Kinnunen, J. Piuhola, H. Ruskoaho, and I. Szokodi AM reverses pressor response to ET-1 independently of NO in rat coronary circulation Am J Physiol Heart Circ Physiol, September 1, 2001; 281(3): H1178 - H1183. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. B. Taner, S. R. Severson, P. J. M. Best, A. Lerman, and V. M. Miller Treatment with endothelin-receptor antagonists increases NOS activity in hypercholesterolemia J Appl Physiol, March 1, 2001; 90(3): 816 - 820. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. H. Wilson, R. D. Simari, P. J. M. Best, T. E. Peterson, L. O. Lerman, M. Aviram, K. A. Nath, D. R. Holmes Jr, and A. Lerman Simvastatin Preserves Coronary Endothelial Function in Hypercholesterolemia in the Absence of Lipid Lowering Arterioscler. Thromb. Vasc. Biol., January 1, 2001; 21(1): 122 - 128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mohlenkamp, L. O. Lerman, A. Lerman, T. R. Behrenbeck, Z. S. Katusic, P. F. Sheedy II, and E. L. Ritman Minimally Invasive Evaluation of Coronary Microvascular Function by Electron Beam Computed Tomography Circulation, November 7, 2000; 102(19): 2411 - 2416. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Cardillo, C. M. Kilcoyne, R. O. Cannon III, and J. A. Panza Increased activity of endogenous endothelin in patients with hypercholesterolemia J. Am. Coll. Cardiol., November 1, 2000; 36(5): 1483 - 1488. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.’i. Sato, T. Mohacsi, A. Noel, C. Jost, P. Gloviczki, G. Mozes, Z. S. Katusic, T. O’Brien, and W. G. Mayhan In Vivo Gene Transfer of Endothelial Nitric Oxide Synthase to Carotid Arteries From Hypercholesterolemic Rabbits Enhances Endothelium-Dependent Relaxations • Editorial Comment Stroke, April 1, 2000; 31(4): 968 - 975. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Rinder, R. J. Spina, and A. A. Ehsani Enhanced endothelium-dependent vasodilation in older endurance-trained men J Appl Physiol, February 1, 2000; 88(2): 761 - 766. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Palombo, V. Lubrano, and T. Sampietro Oxidative stress, F2-isoprostanes and endothelial dysfunction in hypercholesterolemia Cardiovasc Res, December 1, 1999; 44(3): 474 - 476. [Full Text] [PDF]
|
|
|
|
|
|
S. H. Wilson, P. J.M. Best, L. O. Lerman, D. R. Holmes Jr., D. M. Richardson, and A. Lerman Enhanced coronary vasoconstriction to oxidative stress product, 8-epi-prostaglandinF2{alpha}, in experimental hypercholesterolemia Cardiovasc Res, December 1, 1999; 44(3): 601 - 607. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. M. Best, L. O. Lerman, J. C. Romero, D. Richardson, D. R. Holmes Jr, and A. Lerman Coronary Endothelial Function Is Preserved With Chronic Endothelin Receptor Antagonism in Experimental Hypercholesterolemia In Vitro Arterioscler. Thromb. Vasc. Biol., November 1, 1999; 19(11): 2769 - 2775. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Feldstein, J. D. Krier, M. H. Sarafov, A. Lerman, P. J. M. Best, S. H. Wilson, and L. O. Lerman In Vivo Renal Vascular and Tubular Function in Experimental Hypercholesterolemia Hypertension, October 1, 1999; 34(4): 859 - 864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. K. Pfefferkorn, H.-P. Knuppel, B. R. Jaeger, J. Thiery, and G. F. Hamann Increased Cerebral CO2 Reactivity After Heparin-Mediated Extracorporal LDL Precipitation (HELP) in Patients With Coronary Heart Disease and Hyperlipidemia Stroke, September 1, 1999; 30 (9): e1802 - 1806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Hasdai, M. F. Nielsen, R. A. Rizza, D. R. Holmes Jr, D. M. Richardson, P. Cohen, and A. Lerman Attenuated In Vitro Coronary Arteriolar Vasorelaxation to Insulin-like Growth Factor I in Experimental Hypercholesterolemia Hypertension, July 1, 1999; 34(1): 89 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. J. M. Best, C. J. McKenna, D. Hasdai, D. R. Holmes Jr, and A. Lerman Chronic Endothelin Receptor Antagonism Preserves Coronary Endothelial Function in Experimental Hypercholesterolemia Circulation, April 6, 1999; 99(13): 1747 - 1752. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kakoki, Y. Hirata, H. Hayakawa, A. Tojo, D. Nagata, E. Suzuki, K. Kimura, A. Goto, K. Kikuchi, T. Nagano, et al. Effects of Hypertension, Diabetes Mellitus, and Hypercholesterolemia on Endothelin Type B Receptor–Mediated Nitric Oxide Release From Rat Kidney Circulation, March 9, 1999; 99(9): 1242 - 1248. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Hasdai, R. A. Rizza, D. R. Holmes Jr, D. M. Richardson, P. Cohen, and A. Lerman Insulin and Insulin-like Growth Factor-I Cause Coronary Vasorelaxation In Vitro Hypertension, August 1, 1998; 32(2): 228 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Lerman, J. C. Burnett Jr, S. T. Higano, L. J. McKinley, and D. R. Holmes Jr Long-term L-Arginine Supplementation Improves Small-Vessel Coronary Endothelial Function in Humans Circulation, June 2, 1998; 97(21): 2123 - 2128. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Hasdai, P. J.M. Best, C. R. Cannan, V. Mathew, R. S. Schwartz, D. R. Holmes Jr, and A. Lerman Acute Endothelin-Receptor Inhibition Does Not Attenuate Acetylcholine-Induced Coronary Vasoconstriction in Experimental Hypercholesterolemia Arterioscler. Thromb. Vasc. Biol., January 1, 1998; 18(1): 108 - 113. [Abstract] [Full Text] [PDF]
|
|